167 related articles for article (PubMed ID: 34692505)
1. Comparison of: (2
Miner MWG; Liljenbäck H; Virta J; Helin S; Eskola O; Elo P; Teuho J; Seppälä K; Oikonen V; Yang G; Kindler-Röhrborn A; Minn H; Li XG; Roivainen A
Front Oncol; 2021; 11():730358. PubMed ID: 34692505
[TBL] [Abstract][Full Text] [Related]
2. (2S, 4R)-4-[
Miner MW; Liljenbäck H; Virta J; Merisaari J; Oikonen V; Westermarck J; Li XG; Roivainen A
Mol Imaging Biol; 2020 Aug; 22(4):969-978. PubMed ID: 31993927
[TBL] [Abstract][Full Text] [Related]
3. Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2
Palani S; Miner MWG; Virta J; Liljenbäck H; Eskola O; Örd T; Ravindran A; Kaikkonen MU; Knuuti J; Li XG; Saraste A; Roivainen A
Front Immunol; 2022; 13():821423. PubMed ID: 35145523
[TBL] [Abstract][Full Text] [Related]
4. High folate receptor expression in gliomas can be detected
Miner MWG; Liljenbäck H; Virta J; Kärnä S; Viitanen R; Elo P; Gardberg M; Teuho J; Saipa P; Rajander J; Mansour HMA; Cleveland NA; Low PS; Li XG; Roivainen A
Front Immunol; 2023; 14():1145473. PubMed ID: 37275898
[TBL] [Abstract][Full Text] [Related]
5. Imaging Brain Metastasis Patients With 18F-(2S,4R)-4-Fluoroglutamine.
Xu X; Zhu H; Liu F; Zhang Y; Yang J; Zhang L; Zhu L; Li N; Kung HF; Yang Z
Clin Nucl Med; 2018 Nov; 43(11):e392-e399. PubMed ID: 30179907
[TBL] [Abstract][Full Text] [Related]
6. Dynamic PET/CT imaging of
Xu X; Zhu H; Liu F; Zhang Y; Yang J; Zhang L; Xie Q; Zhu L; Li N; Kung HF; Yang Z
Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2280-2292. PubMed ID: 32166510
[TBL] [Abstract][Full Text] [Related]
7. PET/MR Imaging of a Lung Metastasis Model of Clear Cell Renal Cell Carcinoma with (2S,4R)-4-[
Pollard AC; Paolillo V; Radaram B; Qureshy S; Li L; Maity T; Wang L; Uddin MN; Wood CG; Karam JA; Pagel MD; Piwnica-Worms D; Millward SW; Fowlkes NW; Norton W; Engel BJ; Pisaneschi F; Zacharias NM
Mol Imaging Biol; 2022 Dec; 24(6):959-972. PubMed ID: 35732988
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Evaluation of MYCN-Amplified Neuroblastoma by 4-[
Li C; Huang S; Guo J; Wang C; Huang Z; Huang R; Liu L; Liang S; Wang H
Mol Imaging Biol; 2019 Dec; 21(6):1117-1126. PubMed ID: 30850970
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic Assessment of
Grkovski M; Goel R; Krebs S; Staton KD; Harding JJ; Mellinghoff IK; Humm JL; Dunphy MPS
J Nucl Med; 2020 Mar; 61(3):357-366. PubMed ID: 31601700
[No Abstract] [Full Text] [Related]
10. PET Imaging of
Liu F; Xu X; Zhu H; Zhang Y; Yang J; Zhang L; Li N; Zhu L; Kung HF; Yang Z
Mol Pharm; 2018 Aug; 15(8):3448-3455. PubMed ID: 29985631
[TBL] [Abstract][Full Text] [Related]
11. In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of
Dunphy MPS; Harding JJ; Venneti S; Zhang H; Burnazi EM; Bromberg J; Omuro AM; Hsieh JJ; Mellinghoff IK; Staton K; Pressl C; Beattie BJ; Zanzonico PB; Gerecitano JF; Kelsen DP; Weber W; Lyashchenko SK; Kung HF; Lewis JS
Radiology; 2018 May; 287(2):667-675. PubMed ID: 29388903
[TBL] [Abstract][Full Text] [Related]
12. Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo.
Venneti S; Dunphy MP; Zhang H; Pitter KL; Zanzonico P; Campos C; Carlin SD; La Rocca G; Lyashchenko S; Ploessl K; Rohle D; Omuro AM; Cross JR; Brennan CW; Weber WA; Holland EC; Mellinghoff IK; Kung HF; Lewis JS; Thompson CB
Sci Transl Med; 2015 Feb; 7(274):274ra17. PubMed ID: 25673762
[TBL] [Abstract][Full Text] [Related]
13. Comparative enzymology of (2S,4R)4-fluoroglutamine and (2S,4R)4-fluoroglutamate.
Cooper AJ; Krasnikov BF; Pinto JT; Kung HF; Li J; Ploessl K
Comp Biochem Physiol B Biochem Mol Biol; 2012 Sep; 163(1):108-20. PubMed ID: 22613816
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of experimental BT4C glioma models for somatostatin receptor 2-targeted therapies.
Kiviniemi A; Gardberg M; Autio A; Li XG; Heuser VD; Liljenbäck H; Käkelä M; Sipilä H; Kurkipuro J; Ylä-Herttuala S; Knuuti J; Minn H; Roivainen A
Acta Oncol; 2014 Aug; 53(8):1125-34. PubMed ID: 24957558
[TBL] [Abstract][Full Text] [Related]
15. [
Valtorta S; Toscani D; Chiu M; Sartori A; Coliva A; Brevi A; Taurino G; Grioni M; Ruffini L; Vacondio F; Zanardi F; Bellone M; Moresco RM; Bussolati O; Giuliani N
Front Oncol; 2021; 11():760732. PubMed ID: 34712616
[TBL] [Abstract][Full Text] [Related]
16. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of (2S,4S)-4-[
Huang Y; Liu Y; Li C; Li Z; Chen H; Zhang L; Liang Y; Wu Z
Mol Pharm; 2023 Oct; 20(10):5195-5205. PubMed ID: 37647563
[TBL] [Abstract][Full Text] [Related]
18. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas.
Li DL; Xu YK; Wang QS; Wu HB; Li HS
Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472
[TBL] [Abstract][Full Text] [Related]
19. PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine.
Lieberman BP; Ploessl K; Wang L; Qu W; Zha Z; Wise DR; Chodosh LA; Belka G; Thompson CB; Kung HF
J Nucl Med; 2011 Dec; 52(12):1947-55. PubMed ID: 22095958
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
